Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.